The CDT1 gene helps cells prepare to copy their DNA once, and only once, before they divide. If it does not work properly, cells may copy DNA at the wrong time or not complete the process well, which can affect growth and early development. Harmful variants in the CDT1 gene are linked to a rare inherited condition called Meier-Gorlin syndrome, which may include short stature, small ears, and differences in kneecap development.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions for making molecules or managing processes in the body. Some genes provide the directions for building proteins, the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they take place, and how strongly they are carried out. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this subject in more detail, you can read more in the LearnHub.
Overview
CDT1Gene function
What if the gene works
The CDT1 gene helps cells prepare to copy DNA once before division. It helps load the machinery that starts DNA replication, supporting normal growth and tissue renewal.
Risk
What if the gene does not work
Variants in the CDT1 gene can cause a form of Meier-Gorlin syndrome, often leading to short stature, small ears, and small or absent kneecaps. Milder to more severe variants can affect how early features appear and how noticeable they are.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided specifically by a pathogenic variant in the CDT1 gene. The CDT1 gene is being studied in cancer research as a possible biomarker of cell growth and genomic instability, but this has not led to an approved CDT1 directed therapy.
Conditions associated with CDT1
Gene function
What if the gene works
Many of your cells need to copy their DNA before they divide and replace older cells. The CDT1 gene helps organize this early setup step so copying starts in a controlled way. This is a key part of what the CDT1 gene does during cell division and normal tissue renewal.
Cells use the CDT1 gene to prepare spots on DNA where copying can begin before a cell divides. It works early in the cell cycle so the copy process is ready when the cell needs it.
Its protein helps place the MCM complex (a protein machine that opens DNA for copying) onto those prepared spots. This gives the cell the equipment needed to start copying its full set of DNA.
Its activity is limited to a specific stage, so each section of DNA is prepared once during a cell cycle. This supports steady cell renewal in places like the skin, blood, and gut lining.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
CDT1 gene variants can change protein shape, stability, or its ability to bind partner proteins, so cells are less able to prepare DNA for copying. In practice, how CDT1 gene variants affect protein function ranges from milder single-letter DNA changes that leave partial activity to more disruptive variants that sharply reduce the amount of usable protein. When both gene copies are affected, greater loss of CDT1 activity is linked to a more pronounced Meier-Gorlin syndrome pattern.
How variants are linked to conditions
Disease-causing variants in both copies of the CDT1 gene cause Meier-Gorlin syndrome, a rare inherited condition affecting growth and bone development. People with this diagnosis often have marked short stature, small ears, and kneecaps that are very small or hard to see on X-rays or other scans. When CDT1-related Meier-Gorlin syndrome is confirmed on genetic testing, the result helps explain the condition rather than only suggesting a higher future risk.
A variant is not necessarily a diagnosis
Variants in genes are a routine feature of human biology and are widely found across the general population. Most of these variants do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In contrast, there are situations in which one well-defined variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CDT1 gene. For families with a known CDT1 gene change, risk is mainly shaped by whether a child inherits gene changes from both parents, and a doctor or genetic counselor can explain what that means for relatives.
Inheritance of CDT1 variants
For the main well-established CDT1-related condition, variants in the CDT1 gene are inherited in an autosomal recessive pattern. This means a child inherits one altered copy from each parent, and parents are usually healthy carriers. When both parents carry a CDT1 gene variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy. In practical terms, how CDT1 gene variants are inherited usually means the condition appears only when both copies of the gene are affected.
What does my CDT1 result mean for my family?
For families with a disease-causing CDT1 result linked to Meier-Gorlin syndrome, close relatives may also carry the same gene change even if they do not have symptoms. Brothers and sisters may be affected or may be carriers, and parents are often carriers. Family members may want to talk with a genetics professional about what this result means for them and for future children.
Genetic information
Genetic testing
How you find out about variants
A lab can look for changes in the CDT1 gene using DNA from a blood sample, saliva, or a cheek swab. Genetic testing for the CDT1 gene reads the gene’s sequence to check for variants and compares the result with medical databases to help show whether a finding is known to be linked with a health condition or remains uncertain.
When should I consider getting a genetic test?
Genetic testing for the CDT1 gene may be considered when a child has marked growth restriction before and after birth, very small ears, small kneecaps, and short stature, because harmful changes in CDT1 can cause a rare inherited condition called Meier-Gorlin syndrome. Testing can also help clarify the cause when this pattern runs in a family.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal varies with the condition and the specific type of variant. Over time, how the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results can also help place a person’s experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, including how quickly a drug is processed and how strongly it affects you. This helps explain why the same treatment works well for one person, seems weaker in another, or causes more side effects in someone else. These differences are common and can influence both how much benefit a treatment gives and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can shape the way a person responds to medications. It examines links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body handles it. This understanding can support treatment decisions that are better informed and more personalized. You can read more about this topic in the LearnHub.
Drugs influenced by the CDT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response. Questions about side effects, drug interactions, or whether a treatment is right for you are best discussed with your doctor.
History
In the late 1990s and early 2000s, researchers identified the CDT1 gene while studying how cells prepare to copy their DNA before division. Early work in yeast and frog egg extracts helped show that CDT1 was part of a tightly timed system that allows DNA to be copied once per cell cycle. Building on this early work, scientists linked changes in the CDT1 gene to rare human growth conditions, which brought the gene into medical genetics as well as basic cell biology. As medical science evolved, so did understanding of this gene. Today, the CDT1 gene is recognized as an important piece of the history of DNA replication research and of how inherited gene variants can affect development.